SCHEMBL20581440

SCHEMBL20581440

Cn1cc(NC(=O)O)cc1C(=O)Nc1ccc2oc(C(=O)N3CCSCC3)cc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 2/20 0.44
▸ HRAS P01112 4/20 0.43
▸ ESR1 P03372 4/20 0.43
▸ ESR2 Q92731 4/20 0.43
▸ SYK P43405 1/20 0.41
▸ ALDH1A1 P00352 6/20 0.40
▸ RAB9A P51151 5/20 0.40
▸ NPC1 O15118 4/20 0.40
▸ MAPT P10636 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NTSR1 P30989 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20580855 0.91 RAB9A (0.50) HRH4HRASESR1ESR2SYK
SCHEMBL20580879 0.90 RAB9A (0.51) HRH4HRASESR1ESR2SYK
SCHEMBL18976466 0.88 HRAS (0.41) HRH4HRASESR1ESR2SYK
SCHEMBL20581201 0.84 HRH4 (0.41) HRH4SYKALDH1A1RAB9ANPC1
SCHEMBL20580629 0.82 AR (0.49) HRASESR1ESR2ALDH1A1MAPT
SCHEMBL20581209 0.81 HRAS (0.49) HRASESR1ESR2SYKALDH1A1
SCHEMBL20581237 0.80 HRH4 (0.43) HRH4SYKALDH1A1SMN1; SMN2KDM4E
SCHEMBL20581348 0.79 HRAS (0.49) HRASESR1ESR2ALDH1A1RAB9A
SCHEMBL18976462 0.79 NPC1 (0.45) HRH4HRASESR1ESR2SYK
SCHEMBL18976206 0.78 RAB9A (0.46) HRH4HRASESR1ESR2SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed
US-20180354958-A1 PBD ANTIBACTERIAL AGENTS Secretary of State for Health and Social Care (GB) 2018-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS HRH4 13/4885HRAS 3085/4885ESR1 2406/4885
US-20180354958-A1 PBD ANTIBACTERIAL AGENTS OPRD1, XDH, SBDS HRH4 13/4885HRAS 3085/4885ESR1 2406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback